NAP1L1 and NAP1L4 Binding to Hypervariable Domain Of
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Aberrant Methylation Underlies Insulin Gene Expression in Human Insulinoma
ARTICLE https://doi.org/10.1038/s41467-020-18839-1 OPEN Aberrant methylation underlies insulin gene expression in human insulinoma Esra Karakose1,6, Huan Wang 2,6, William Inabnet1, Rajesh V. Thakker 3, Steven Libutti4, Gustavo Fernandez-Ranvier 1, Hyunsuk Suh1, Mark Stevenson 3, Yayoi Kinoshita1, Michael Donovan1, Yevgeniy Antipin1,2, Yan Li5, Xiaoxiao Liu 5, Fulai Jin 5, Peng Wang 1, Andrew Uzilov 1,2, ✉ Carmen Argmann 1, Eric E. Schadt 1,2, Andrew F. Stewart 1,7 , Donald K. Scott 1,7 & Luca Lambertini 1,6 1234567890():,; Human insulinomas are rare, benign, slowly proliferating, insulin-producing beta cell tumors that provide a molecular “recipe” or “roadmap” for pathways that control human beta cell regeneration. An earlier study revealed abnormal methylation in the imprinted p15.5-p15.4 region of chromosome 11, known to be abnormally methylated in another disorder of expanded beta cell mass and function: the focal variant of congenital hyperinsulinism. Here, we compare deep DNA methylome sequencing on 19 human insulinomas, and five sets of normal beta cells. We find a remarkably consistent, abnormal methylation pattern in insu- linomas. The findings suggest that abnormal insulin (INS) promoter methylation and altered transcription factor expression create alternative drivers of INS expression, replacing cano- nical PDX1-driven beta cell specification with a pathological, looping, distal enhancer-based form of transcriptional regulation. Finally, NFaT transcription factors, rather than the cano- nical PDX1 enhancer complex, are predicted to drive INS transactivation. 1 From the Diabetes Obesity and Metabolism Institute, The Department of Surgery, The Department of Pathology, The Department of Genetics and Genomics Sciences and The Institute for Genomics and Multiscale Biology, The Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. -
Research Article Characterization, Tissue Expression, and Imprinting Analysis of the Porcine CDKN1C and NAP1L4 Genes
Hindawi Publishing Corporation Journal of Biomedicine and Biotechnology Volume 2012, Article ID 946527, 7 pages doi:10.1155/2012/946527 Research Article Characterization, Tissue Expression, and Imprinting Analysis of the Porcine CDKN1C and NAP1L4 Genes Shun Li,1 Juan Li,1 Jiawei Tian,1 Ranran Dong,1 Jin Wei,1 Xiaoyan Qiu,2 and Caode Jiang2 1 School of Life Science, Southwest University, Chongqing 400715, China 2 College of Animal Science and Technology, Southwest University, Chongqing 400715, China Correspondence should be addressed to Caode Jiang, [email protected] Received 4 August 2011; Revised 25 October 2011; Accepted 15 November 2011 Academic Editor: Andre Van Wijnen Copyright © 2012 Shun Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. CDKN1C and NAP1L4 in human CDKN1C/KCNQ1OT1 imprinted domain are two key candidate genes responsible for BWS (Beckwith-Wiedemann syndrome) and cancer. In order to increase understanding of these genes in pigs, their cDNAs are characterized in this paper. By the IMpRH panel, porcine CDKN1C and NAP1L4 genes were assigned to porcine chromosome 2, closely linked with IMpRH06175 and with LOD of 15.78 and 17.94, respectively. By real-time quantitative RT-PCR and polymorphism-based method, tissue and allelic expression of both genes were determined using F1 pigs of Rongchang and Landrace reciprocal crosses. The transcription levels of porcine CDKN1C and NAP1L4 were significantly higher in placenta than in other neonatal tissues (P<0.01) although both genes showed the highest expression levels in the lung and kidney of one- month pigs (P<0.01). -
Snps) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction S
Supplemental material to this article can be found at: http://dmd.aspetjournals.org/content/suppl/2018/07/06/dmd.118.082164.DC1 1521-009X/46/9/1372–1381$35.00 https://doi.org/10.1124/dmd.118.082164 DRUG METABOLISM AND DISPOSITION Drug Metab Dispos 46:1372–1381, September 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction s Duan Liu, Sisi Qin, Balmiki Ray,1 Krishna R. Kalari, Liewei Wang, and Richard M. Weinshilboum Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics (D.L., S.Q., B.R., L.W., R.M.W.) and Division of Biomedical Statistics and Informatics, Department of Health Sciences Research (K.R.K.), Mayo Clinic, Rochester, Minnesota Received April 22, 2018; accepted June 28, 2018 ABSTRACT Downloaded from CYP1A1 expression can be upregulated by the ligand-activated aryl fashion. LCLs with the AA genotype displayed significantly higher hydrocarbon receptor (AHR). Based on prior observations with AHR-XRE binding and CYP1A1 mRNA expression after 3MC estrogen receptors and estrogen response elements, we tested treatment than did those with the GG genotype. Electrophoretic the hypothesis that single-nucleotide polymorphisms (SNPs) map- mobility shift assay (EMSA) showed that oligonucleotides with the ping hundreds of base pairs (bp) from xenobiotic response elements AA genotype displayed higher LCL nuclear extract binding after (XREs) might influence AHR binding and subsequent gene expres- 3MC treatment than did those with the GG genotype, and mass dmd.aspetjournals.org sion. -
Aneuploidy: Using Genetic Instability to Preserve a Haploid Genome?
Health Science Campus FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Science (Cancer Biology) Aneuploidy: Using genetic instability to preserve a haploid genome? Submitted by: Ramona Ramdath In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Science Examination Committee Signature/Date Major Advisor: David Allison, M.D., Ph.D. Academic James Trempe, Ph.D. Advisory Committee: David Giovanucci, Ph.D. Randall Ruch, Ph.D. Ronald Mellgren, Ph.D. Senior Associate Dean College of Graduate Studies Michael S. Bisesi, Ph.D. Date of Defense: April 10, 2009 Aneuploidy: Using genetic instability to preserve a haploid genome? Ramona Ramdath University of Toledo, Health Science Campus 2009 Dedication I dedicate this dissertation to my grandfather who died of lung cancer two years ago, but who always instilled in us the value and importance of education. And to my mom and sister, both of whom have been pillars of support and stimulating conversations. To my sister, Rehanna, especially- I hope this inspires you to achieve all that you want to in life, academically and otherwise. ii Acknowledgements As we go through these academic journeys, there are so many along the way that make an impact not only on our work, but on our lives as well, and I would like to say a heartfelt thank you to all of those people: My Committee members- Dr. James Trempe, Dr. David Giovanucchi, Dr. Ronald Mellgren and Dr. Randall Ruch for their guidance, suggestions, support and confidence in me. My major advisor- Dr. David Allison, for his constructive criticism and positive reinforcement. -
Macrophage Activation JUNB Is a Key Transcriptional Modulator Of
JUNB Is a Key Transcriptional Modulator of Macrophage Activation Mary F. Fontana, Alyssa Baccarella, Nidhi Pancholi, Miles A. Pufall, De'Broski R. Herbert and Charles C. Kim This information is current as of October 2, 2021. J Immunol 2015; 194:177-186; Prepublished online 3 December 2014; doi: 10.4049/jimmunol.1401595 http://www.jimmunol.org/content/194/1/177 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2014/12/03/jimmunol.140159 Material 5.DCSupplemental References This article cites 40 articles, 7 of which you can access for free at: http://www.jimmunol.org/content/194/1/177.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 2, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2014 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology JUNB Is a Key Transcriptional Modulator of Macrophage Activation Mary F. Fontana,* Alyssa Baccarella,* Nidhi Pancholi,* Miles A. -
Letters to the Editor J Med Genet: First Published As 10.1136/Jmg.37.3.231 on 1 March 2000
210 Letters Letters to the Editor J Med Genet: first published as 10.1136/jmg.37.3.231 on 1 March 2000. Downloaded from J Med Genet 2000;37:210–212 No evidence of germline PTEN three reasons: somatic mutations have been found in PTEN in prostate tumours; germline mutations in Cowden mutations in familial prostate cancer disease produce a phenotype (although with no evidence of an associated susceptibility to prostate cancer); and PTEN deficient mice exhibit prostate abnormalities. We have therefore screened the Cancer Research Campaign/British EDITOR—Prostate cancer is the second most common Prostate Group (CRC/BPG) UK Familial Prostate Cancer cause of male cancer mortality in the UK.1 Current indica- Study samples for evidence of PTEN mutations. tions are that like many common cancers, prostate cancer The CRC/BPG UK Familial Prostate Cancer Study has has an inherited component.2 Segregation analysis has led collected lymphocyte DNA from 188 subjects from 50 to the proposed model of at least one highly penetrant, prostate cancer families. These families were chosen dominant gene (with an estimated 88% penetrance for because each contained three or more cases of prostate prostate cancer by the age of 85 in the highly susceptible cancer at any age or related sib pairs where at least one man population). Such a gene or genes would account for an was less than 67 (original criterion was 65) years old at estimated 43% of cases diagnosed at less than 55 years.2 diagnosis. In fact, the majority of the clusters consist of One prostate cancer susceptibility locus (HPC1) has been aVected sib pairs, with DNA often only available from reported on 1q24-253 and confirmed by Cooney et al4 and cases. -
Mclean, Chelsea.Pdf
COMPUTATIONAL PREDICTION AND EXPERIMENTAL VALIDATION OF NOVEL MOUSE IMPRINTED GENES A Dissertation Presented to the Faculty of the Graduate School of Cornell University In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy by Chelsea Marie McLean August 2009 © 2009 Chelsea Marie McLean COMPUTATIONAL PREDICTION AND EXPERIMENTAL VALIDATION OF NOVEL MOUSE IMPRINTED GENES Chelsea Marie McLean, Ph.D. Cornell University 2009 Epigenetic modifications, including DNA methylation and covalent modifications to histone tails, are major contributors to the regulation of gene expression. These changes are reversible, yet can be stably inherited, and may last for multiple generations without change to the underlying DNA sequence. Genomic imprinting results in expression from one of the two parental alleles and is one example of epigenetic control of gene expression. So far, 60 to 100 imprinted genes have been identified in the human and mouse genomes, respectively. Identification of additional imprinted genes has become increasingly important with the realization that imprinting defects are associated with complex disorders ranging from obesity to diabetes and behavioral disorders. Despite the importance imprinted genes play in human health, few studies have undertaken genome-wide searches for new imprinted genes. These have used empirical approaches, with some success. However, computational prediction of novel imprinted genes has recently come to the forefront. I have developed generalized linear models using data on a variety of sequence and epigenetic features within a training set of known imprinted genes. The resulting models were used to predict novel imprinted genes in the mouse genome. After imposing a stringency threshold, I compiled an initial candidate list of 155 genes. -
Is Associated with Hypomethylation At
797 ORIGINAL ARTICLE J Med Genet: first published as 10.1136/jmg.40.11.797 on 19 November 2003. Downloaded from Silencing of CDKN1C (p57KIP2) is associated with hypomethylation at KvDMR1 in Beckwith–Wiedemann syndrome N Diaz-Meyer, C D Day, K Khatod, E R Maher, W Cooper, W Reik, C Junien, G Graham, E Algar, V M Der Kaloustian, M J Higgins ............................................................................................................................... J Med Genet 2003;40:797–801 Context: Beckwith–Wiedemann syndrome (BWS) arises by several genetic and epigenetic mechanisms affecting the balance of imprinted gene expression in chromosome 11p15.5. The most frequent alteration associated with BWS is the absence of methylation at the maternal allele of KvDMR1, an intronic CpG island within the KCNQ1 gene. Targeted deletion of KvDMR1 suggests that this locus is an imprinting control region (ICR) that regulates multiple genes in 11p15.5. Cell culture based enhancer blocking assays indicate that KvDMR1 may function as a methylation modulated chromatin insulator and/or silencer. See end of article for Objective: To determine the potential consequence of loss of methylation (LOM) at KvDMR1 in the authors’ affiliations ....................... development of BWS. Methods: The steady state levels of CDKN1C gene expression in fibroblast cells from normal individuals, Correspondence to: and from persons with BWS who have LOM at KvDMR1, was determined by both real time quantitative M J Higgins, Department of Cancer Genetics, polymerase chain reaction (qPCR) and ribonuclease protection assay (RPA). Methylation of the CDKN1C Roswell Park Cancer promoter region was assessed by Southern hybridisation using a methylation sensitive restriction Institute, Buffalo, NY endonuclease. 14263, USA; michael.higgins@ Results: Both qPCR and RPA clearly demonstrated a marked decrease (86–93%) in the expression level of roswellpark.org the CDKN1C gene in cells derived from patients with BWS, who had LOM at KvDMR1. -
NAP1L1: a Novel Human Colorectal Cancer Biomarker Derived from Animal Models of Apc Inactivation
fonc-10-01565 August 7, 2020 Time: 19:2 # 1 ORIGINAL RESEARCH published: 11 August 2020 doi: 10.3389/fonc.2020.01565 NAP1L1: A Novel Human Colorectal Cancer Biomarker Derived From Animal Models of Apc Inactivation Cleberson J. S. Queiroz1,2, Fei Song1,3, Karen R. Reed4,5, Nadeem Al-Khafaji1, Alan R. Clarke5†, Dale Vimalachandran6, Fabio Miyajima1,7, D. Mark Pritchard1* and John R. Jenkins1 1 Institute of Systems, Molecular and Integrative Biology, Henry Wellcome Laboratory, University of Liverpool, Liverpool, United Kingdom, 2 Faculty of Medicine, Federal University of Mato Grosso (UFMT), Cuiaba, Brazil, 3 INFRAFRONTIER GmbH, Neuherberg, Germany, 4 Wales Gene Park, Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, United Kingdom, 5 European Cancer Stem Cell Research Institute, Cardiff University School of Biosciences, Cardiff, United Kingdom, 6 Department of Colorectal Surgery, Countess of Chester Hospital NHS Foundation Trust, Chester, Edited by: United Kingdom, 7 Molecular Epidemiology Laboratory, Oswaldo Cruz Foundation, Eusebio, Brazil Boris Zhivotovsky, Karolinska Institutet (KI), Sweden Introduction: Colorectal cancer (CRC) is the second leading cause of cancer death Reviewed by: Giovanna Caderni, worldwide and most deaths result from metastases. We have analyzed animal models University of Florence, Italy in which Apc, a gene that is frequently mutated during the early stages of colorectal Gabriele Multhoff, carcinogenesis, was inactivated and human samples to try to identify novel potential Technical University of Munich, Germany biomarkers for CRC. *Correspondence: Materials and Methods: We initially compared the proteomic and transcriptomic D. Mark Pritchard [email protected]; profiles of the small intestinal epithelium of transgenic mice in which Apc and/or Myc [email protected] had been inactivated. -
NAP1L1-MLLT10 Is a Rare Recurrent Translocation That Is Associated With
NAP1L1-MLLT10 is a rare recurrent translocation that is associated with HOXA activation and poor treatment response in T-cell acute lymphoblastic leukaemia Jonathan Bond, Aurore Touzart, Agata Cieslak, Amélie Trinquand, Tony Marchand, Martine Escoffre, Audrey Contet, Marc Muller, Claudine Schmitt, Thierry Fest, et al. To cite this version: Jonathan Bond, Aurore Touzart, Agata Cieslak, Amélie Trinquand, Tony Marchand, et al.. NAP1L1- MLLT10 is a rare recurrent translocation that is associated with HOXA activation and poor treatment response in T-cell acute lymphoblastic leukaemia. British Journal of Haematology, Wiley, 2016, 174 (3), pp.470-473. 10.1111/bjh.13772. hal-01217983 HAL Id: hal-01217983 https://hal-univ-rennes1.archives-ouvertes.fr/hal-01217983 Submitted on 14 Jan 2016 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. NAP1L1-MLLT10 is a rare recurrent translocation that is associated with HOXA activation and poor treatment response in T-cell acute lymphoblastic leukaemia. Correspondence Jonathan Bond1,2, Aurore Touzart1,2, Agata Cieslak1,2, -
Nucleosome Eviction and Activated Transcription Require P300 Acetylation of Histone H3 Lysine 14
Nucleosome eviction and activated transcription require p300 acetylation of histone H3 lysine 14 Whitney R. Luebben1, Neelam Sharma1, and Jennifer K. Nyborg2 Department of Biochemistry and Molecular Biology, Campus Box 1870, Colorado State University, Fort Collins, CO 80523 Edited by Mark T. Groudine, Fred Hutchinson Cancer Research Center, Seattle, WA, and approved September 9, 2010 (received for review July 6, 2010) Histone posttranslational modifications and chromatin dynamics include H4 acetylation-dependent relaxation of the chromatin are inextricably linked to eukaryotic gene expression. Among fiber and recruitment of ATP-dependent chromatin-remodeling the many modifications that have been characterized, histone tail complexes via acetyl-lysine binding bromodomains (12–17). acetylation is most strongly correlated with transcriptional activa- However, the mechanism by which histone tail acetylation elicits tion. In Metazoa, promoters of transcriptionally active genes are chromatin reconfiguration and coupled transcriptional activation generally devoid of physically repressive nucleosomes, consistent is unknown (6). with the contemporaneous binding of the large RNA polymerase II In recent years, numerous high profile mapping studies of transcription machinery. The histone acetyltransferase p300 is also nucleosomes and their modifications identified nucleosome-free detected at active gene promoters, flanked by regions of histone regions (NFRs) at the promoters of transcriptionally active genes hyperacetylation. Although the correlation -
Associated with Spherical Equivalent
Molecular Vision 2016; 22:783-796 <http://www.molvis.org/molvis/v22/783> © 2016 Molecular Vision Received 20 August 2015 | Accepted 12 July 2016 | Published 14 July 2016 Variation in PTCHD2, CRISP3, NAP1L4, FSCB, and AP3B2 associated with spherical equivalent Fei Chen,1 Priya Duggal,1 Barbara E.K. Klein,2 Kristine E. Lee,2 Barbara Truitt,3 Ronald Klein,2 Sudha K. Iyengar,3 Alison P. Klein1,4,5 1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; 2Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI; 3Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH; 4Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; 5Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD Purpose: Ocular refraction is measured in spherical equivalent as the power of the external lens required to focus images on the retina. Myopia (nearsightedness) and hyperopia (farsightedness) are the most common refractive errors, and the leading causes of visual impairment and blindness in the world. The goal of this study is to identify rare and low-frequency variants that influence spherical equivalent. Methods: We conducted variant-level and gene-level quantitative trait association analyses for mean spherical equiva- lent, using data from 1,560 individuals in the Beaver Dam Eye Study. Genotyping was conducted using the Illumina exome array. We analyzed 34,976 single nucleotide variants and 11,571 autosomal genes across the genome, using single-variant tests as well as gene-based tests. Results: Spherical equivalent was significantly associated with five genes in gene-based analysis: PTCHD2 at 1p36.22 (p = 3.6 × 10−7), CRISP3 at 6p12.3 (p = 4.3 × 10−6), NAP1L4 at 11p15.5 (p = 3.6 × 10−6), FSCB at 14q21.2 (p = 1.5 × 10−7), and AP3B2 at 15q25.2 (p = 1.6 × 10−7).